GGrantIndex
← Search

NOVEL COMBINATION IMMUNE THERAPY REGIMENS FOR METASTATIC BREAST CANCER

$780,749FY2025Defense Health AgencyDOD

Health Research, Inc., Rockville MD

Investigators

View source on USAspending →
NOVEL COMBINATION IMMUNE THERAPY REGIMENS FOR METASTATIC BREAST CANCER · GrantIndex